scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1037792543 |
P356 | DOI | 10.2165/11539250-000000000-00000 |
P698 | PubMed publication ID | 21456631 |
P2093 | author name string | Johan W Smit | |
Ron A H J Gilissen | |||
Claire E Mackie | |||
Luca A Fenu | |||
Stefan S De Buck | |||
Vikash K Sinha | |||
Achiel Van Peer | |||
Marjoleen Nijsen | |||
Eva Hoeben | |||
Wendy Sanderson | |||
Karin Vaarties | |||
Kelly Van Uytsel | |||
P2860 | cites work | Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data | Q30697908 |
Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations | Q33605312 | ||
Scaling basic toxicokinetic parameters from rat to man. | Q34635619 | ||
Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data | Q36857756 | ||
The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. | Q36886681 | ||
Estimating xenobiotic half-lives in humans from rat data: influence of log P. | Q36891261 | ||
Species similarities and differences in pharmacokinetics. | Q41001138 | ||
Interspecies scaling: predicting clearance of drugs in humans. Three different approaches | Q41189275 | ||
Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices | Q41676765 | ||
Predicting oral clearance in humans: how close can we get with allometry? | Q51898567 | ||
A compartmental absorption and transit model for estimating oral drug absorption. | Q52204779 | ||
Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestions. | Q52240880 | ||
Some suggestions for measuring predictive performance | Q52875851 | ||
Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs. | Q53024733 | ||
Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals | Q70507453 | ||
Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics | Q73933451 | ||
Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs | Q78498262 | ||
Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmacokinetics to man | Q81445372 | ||
P433 | issue | 5 | |
P921 | main subject | allometry | Q519888 |
P304 | page(s) | 307-318 | |
P577 | publication date | 2011-05-01 | |
P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
P1476 | title | Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry | |
P478 | volume | 50 |
Q30844731 | First dose in neonates: are juvenile mice, adults and in vitro-in silico data predictive of neonatal pharmacokinetics of fluconazole |
Q42680392 | Interspecies modeling and prediction of human exenatide pharmacokinetics |
Q52690032 | Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics. |
Q33955715 | Prediction of human oral plasma concentration-time profiles using preclinical data: comparative evaluation of prediction approaches in early pharmaceutical discovery |
Q37216720 | Whole-exome sequencing identifies novel LEPR mutations in individuals with severe early onset obesity |